December 24, 2024 04:31 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
India refrains from commenting on extradition request for ousted Bengladeshi PM Sheikh Hasina | I don't blame Allu Arjun, ready to withdraw case: Pushpa 2 stampede victim's husband | Indian New Wave Cinema Architect Shyam Benegal dies at age 90 | Cylinder blast at a temple in Karnataka's Hubbali injures nine people | Kuwait PM personally sees off Modi at airport as Indian premier concludes two-day trip | Three pro-Khalistani terrorists, who attacked a police outpost in Gurdaspur, killed in an encounter | Who is Sriram Krishnan, an Indian-American picked by Donald Trump as US AI policy advisor? | Mohali building collapse: Death toll rises to 2, many feared trapped for 17 hours | 4-year-old killed after speeding car driven by a teen hits him in Mumbai | PM Modi attends opening ceremony of Arabian Gulf Cup in Kuwait
Honeywell
Image: Honeywell Twitter Handle

Honeywell launches authentication technology to prevent counterfeit pharma products

| @indiablooms | Jun 22, 2021, at 01:01 am

Bengaluru/UNI: Honeywell on Monday announced digital authentication technology for pharmaceutical products in a bid to fight rising counterfeit crime in India.

In a statement issued here, the company said an acute shortage of drugs to treat symptoms of COVID-19 has led to increased circulation of counterfeit medicines in recent times.

There are reports of fake antiviral medicines and spurious injectable immunosuppressants in the market, jeopardizing the lives of COVID-19 patients, and even leading to fatalities, the company said.

With the rising demand for vaccines, there is concern that fake vaccines could find their way into circulation.

Earlier this year, the World Health Organization alerted over criminal exploitation of unmet global demand for COVID-19 vaccines.

Already, counterfeit vaccines have been detected in countries such as Mexico and Poland.

The coronavirus pandemic has led to an influx of fake medical products worldwide. Interpol’s Operation Pangea reported a rise in fake medical products related to the pandemic, with 4.4 million units valued at $14M having been seized in 2020 alone.

Worryingly, counterfeiting is not restricted to COVID-19 vaccines and medicines alone. Per one report, 10% of drugs in circulation in low- and middle-income countries are either counterfeit or substandard.

“Honeywell is deploying its authentication technology for the pharmaceutical industry in response to the growing menace of counterfeit products,” said Hitesh Mehta, General Manager, Advanced Materials, Honeywell India.

“Our sophisticated authentication technologies feature printing and substrates which can be easily identified but are difficult to alter and duplicate. Our technology offers brand protection for manufacturers and assurance of authentic products for end-users," he said.

The solution comprises a digital code that is embedded in the packaging of pharmaceutical products, officials shared.

The end-user can validate the authenticity of the product by scanning the digital code with the help of a smartphone letting the end-party know whether it is safe to use.

The software that validates the product’s authenticity through a database is accessible through a Honeywell app available for download for iOS and Android users and gathers market intelligence, the company officials added.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.